Download Document

Publications of Ariko Miyake
1. Enose, Y., Ui, M., Miyake, A., Suzuki, H., Uesaka, H., Kuwata, T., Kunisawa, J., Kiyono, H.,
Takahashi, H., Miura, T., and Hayami, M. 2002. Protection by intranasal immunization of a
nef-deleted, non-pathogenic SHIV against intravaginal challenge with a heterologous pathogenic
SHIV. Virology 298: 306-316.
2. Enose, Y., Miyake, A., Ido, E., and Hayami, M. 2003. Infection of a chimeric simian and human
immunodeficiency virus with CCR5-specific HIV-1 envelope to rhesus macaques. The Journal of
Veterinary Medical Science 65: 283-286.
3. Miyake, A., Enose, Y., Ohkura, S., Suzuki, H., Kuwata, T., Shimada, T., Kato, S., Narayan, O., and
Hayami, M. 2004. The quantity and diversity of infectious viruses in various tissues of
SHIV-infected monkeys at early and AIDS Stages. Archives of Virology 149: 943-55.
4. Miyake, A., Akagi, T., Enose, Y., Ueno, M., Kawamura, M., Horiuchi, R., Hiraishi, K., Adachi, M.,
Serizawa, T., Narayan, O., Akashi, M., Baba, M., and Hayami, M. 2004. Induction of SHIV-specific
vaginal antibody response and protection of macaques against vaginal transmission of a pathogenic
SHIV by intranasal immunization with inactivated SHIV-capturing nanospheres. Journal of Medical
Virology 73: 368-377.
5. Enose, Y., Kita, M., Yamamoto, T., Suzuki, H., Miyake, A., Horiuchi, R., Ibuki, K., Kaneyasu, K.,
Kuwata, T., Takahashi, E., Sakai, K., Shinohara, K., Miura, T., and Hayami, M. 2004. Protective
effects of nef-deleted SHIV or that having IFN-gamma against disease induced with a pathogenic
virus early after vaccination. Archives of Virology 149: 1705-1720.
6. Suzuki, H., Motohara, M., Miyake, A., Ibuki, K., Fukazawa, Y., Inaba, K., Masuda, K., Minato, N.,
Kawamoto, H., Hayami, M., and *Miura, T. 2005. Intrathymic effect of acute pathogenic SHIV
infection on T-lineage cells in newborn macaques. Microbiology and Immunology 49: 667-679.
7. Miyake, A., Ibuki, K., Suzuki, H., Horiuchi, R., Saito, N., Motohara, M., Hayami, M., and *Miura, T.
2005. Early virological events in various tissues of newborn monkeys after intrarectal infection
with pathogenic simian human immunodeficiency virus. Journal of Medical Primatology 34:
294-302.
8. Kamoi, K., Yamamoto, K., Misawa, A., Miyake, A., Ishida, T., Tanaka, Y., Mochizuki, M., and
*Watanabe, T. 2006. SUV39H1 interacts with HTLV-1 Tax and abrogates Tax transactivation of
HTLV-1 LTR. Retrovirology 3:5.
9. Horiuchi, R., Akahata, W., Kuwata, T., Enose, Y., Ido, E., Suzuki, H., Miyake, A., Saito, N., Ibuki, K.,
Goto, T., Miura, T., and Hayami, M. 2006. DNA vaccination of macaques by a full-genome SHIV
plasmid that has an IL-2 gene and produces non-infectious virus particles. Vaccine 24: 3677-3685.
10. Motohara, M., Ibuki, K., Miyake, A., Fukazawa, Y., Inaba, K., Suzuki, H., Masuda, K., Minato, N.,
Kawamoto, H., Nakasone, T., Honda, M., Hayami, M., and Miura, T. 2006. Impaired T cell
differentiation in the thymus at the early stages of acute pathogenic SHIV infection in contrast to less
pathogenic SHIV infection. Microbes and Infection 8: 1539-1549.
11. Miyake, A., Ibuki, K., Enose, Y., Suzuki, H., Horiuchi, R., Motohara, M., Saito, N., Nakasone, T.,
Honda, M., Watanabe, T., Miura, T., and *Hayami, M. 2006. Rapid dissemination of a pathogenic
simian/human immunodeficiency virus to systemic organs and active replication in lymphoid tissues
following intrarectal infection. Journal of General Virology 87: 1311-1320.
12. Miyake, A., Dewan, M.Z., Ishida, T., Watanabe, M., Honda, M., Sata, T., Yamamoto, N., Umezawa,
K., Watanabe, T., and Horie, R. 2008. Induction of apoptosis in Epstein-Barr virus-infected
B-lymphocytes by the NF-kappaB inhibitor DHMEQ. Microbes and Infection 10: 748-756.
13. Fukazawa, Y.*, Miyake, A.*, Ibuki, K., Inaba, K., Saito, N., Motohara, M., Horiuchi, R., Himeno, A.,
Matsuda, K., Matsuyama, M., Takahashi, H., Hayami, M., Igarashi, T., and Miura, T. (*contributed
equally) 2008. Small intestine CD4+ T cells are profoundly depleted during acute simian-human
immunodeficiency virus infection, regardless of viral pathogenicity. Journal of Virology 82:
6039-6044.
14. Yamagishi, M., Ishida, T., Miyake, A., Cooper, D.A., Kelleher, A.D., Suzuki, K., and Watanabe, T.
2009. Retroviral delivery of Promoter-targeted shRNA induces long-term silencing of HIV-1
transcription. Microbes and Infection 11: 500-508.
15. Dabaghmanesh, N., Matsubara, A., Miyake, A., Nakano, K., Ishida, T., Katano, H., Horie, R.,
Umezawa, K., and Watanabe, T. 2009. Transient inhibition of NF-kappaB by DHMEQ induces cell
death of primary effusion lymphoma without HHV-8 reactivation. Cancer Science 100: 737-746.
16. Yamashita, T., Nomaguchi, M., Miyake, A., Uchiyama, T., and Adachi, A. 2010. Status of
APOBEC3G/F in cells and progeny virions modulated by Vif determines HIV-1 infectivity. Microbes
and Infection 12: 166-171.
17. Nagao, T., Yamashita, T., Miyake, A., Uchiyama, T., Nomaguchi, M., and Adachi, A. 2010.
Different interaction between HIV-1 Vif and its cellular target proteins APOBEC3G/APOBEC3F.
Journal of Medical Investigation, 57: 89-94.
18. Miyake, A., Ishida, T., Yamagishi, M., Hara, T., Umezawa, K., Watanabe, T., and Horie, R. 2010.
Inhibition of active HIV-1 replication by NF-κB inhibitor DHMEQ. Microbes and Infection 12:
400-408.